Elizabeth M Poole
Affiliation: Harvard University
- Genetic variability in IGF-1 and IGFBP-3 and body size in early lifeElizabeth M Poole
Department of Medicine, Channing Laboratory, Brigham and Women s Hospital and Harvard Medical School, Boston, MA 02115, USA
BMC Public Health 12:659. 2012..Previous studies have examined the role of IGF-1 and IGFBP-3 genetic variation in relation to adult height and body size, but few studies have examined associations with birthweight and childhood size...
- Body size in early life and adult levels of insulin-like growth factor 1 and insulin-like growth factor binding protein 3Elizabeth M Poole
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115, USA
Am J Epidemiol 174:642-51. 2011..These findings suggest that altered IGF-1 levels in adulthood may be a mechanism through which early-life body size influences subsequent breast cancer risk...
- Postdiagnosis supplement use and breast cancer prognosis in the After Breast Cancer Pooling ProjectElizabeth M Poole
Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA, USA
Breast Cancer Res Treat 139:529-37. 2013..Stratification by ER status and considering antioxidants as a group may be more clinically relevant when evaluating associations with cancer risk and mortality...
- Hormonal and reproductive risk factors for epithelial ovarian cancer by tumor aggressivenessElizabeth M Poole
Corresponding Author Elizabeth M Poole, Channing Laboratory, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 22:429-37. 2013....
- ABO blood group and risk of epithelial ovarian cancer within the Ovarian Cancer Association ConsortiumElizabeth M Poole
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, 181 Longwood Ave, 3rd Floor, Boston, MA 02115, USA
Cancer Causes Control 23:1805-10. 2012..Previous studies have examined the association between ABO blood group and ovarian cancer risk, with inconclusive results...
- The After Breast Cancer Pooling Project: rationale, methodology, and breast cancer survivor characteristicsSarah J Nechuta
Division of Epidemiology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN 37203 1738, USA
Cancer Causes Control 22:1319-31. 2011..The project sets the stage for international collaborations for the investigation of modifiable predictors for breast cancer outcomes...
- Acrylamide hemoglobin adduct levels and ovarian cancer risk: a nested case-control studyJing Xie
Corresponding Author Shelley S Tworoger, Channing Division of Network Medicine, Department of Medicine, Brigham and Women s Hospital and Harvard Medical School, 181 Longwood Avenue, Boston, MA 02115
Cancer Epidemiol Biomarkers Prev 22:653-60. 2013..Two large prospective cohort studies of dietary acrylamide intake and ovarian cancer risk observed a positive association, although two other studies reported no association...
- Genetic variability in IL23R and risk of colorectal adenoma and colorectal cancerElizabeth M Poole
Fred Hutchinson Cancer Research Center, Seattle, WA 98109, USA
Cancer Epidemiol 36:e104-10. 2012..These data provide some evidence that genetic variability in IL23R may contribute to rectal cancer risk and should be evaluated in additional studies...
- Rotating night shift work and risk of ovarian cancerElizabeth M Poole
Channing Laboratory, Department of Medicine, Brigham and Women s Hospital, Harvard Medical School, Boston, MA 02115, USA
Cancer Epidemiol Biomarkers Prev 20:934-8. 2011..Night shift work has been associated with higher risks of breast and endometrial cancer, but few studies have evaluated associations with other reproductive cancers...